000			02151 a2200589 4500
005			20250516163633.0
264		0	_c20140701
008			201407s 0 0 eng d
022			_a1555-905X
024	7		_a10.2215/CJN.02700313 _2doi
040			_aNLM _beng _cNLM
100	1		_aKaralliedde, Janaka
245	0	0	_aEffect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria. _h[electronic resource]
260			_bClinical journal of the American Society of Nephrology : CJASN _cNov 2013
300			_a1899-905 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAlbuminuria _xblood
650	0	4	_aAmlodipine _xtherapeutic use
650	0	4	_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCalcium Channel Blockers _xtherapeutic use
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDiabetic Nephropathies _xblood
650	0	4	_aDiuretics _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGlucuronidase _xblood
650	0	4	_aHospitals, University
650	0	4	_aHumans
650	0	4	_aHydrochlorothiazide _xtherapeutic use
650	0	4	_aHypertension _xblood
650	0	4	_aKlotho Proteins
650	0	4	_aLondon
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPhosphates _xblood
650	0	4	_aPulse Wave Analysis
650	0	4	_aRenin-Angiotensin System _xdrug effects
650	0	4	_aSystole
650	0	4	_aTetrazoles _xtherapeutic use
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aValine _xanalogs & derivatives
650	0	4	_aValsartan
700	1		_aMaltese, Giuseppe
700	1		_aHill, Benjamin
700	1		_aViberti, Giancarlo
700	1		_aGnudi, Luigi
773	0		_tClinical journal of the American Society of Nephrology : CJASN _gvol. 8 _gno. 11 _gp. 1899-905
856	4	0	_uhttps://doi.org/10.2215/CJN.02700313 _zAvailable from publisher's website
999			_c22989464 _d22989464